AzTrials
AzTrials

Arterial CatheterizationULNARTNCT05258903

Ulnar Artery Versus Radial Artery Cannulation in Paediatric Patients

A study testing Ulnar artery cannulation and Radial artery cannulation in people with Arterial Catheterization, run by Brno University Hospital at 1 site in Czechia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Arterial cannulation is indicated in several clinical settings: high-risk surgery, respiratory failure, circulatory failure. The possible anatomical sites of cannulation are: a.radialis, a.brachialis, a. femoralis. Read more about this study

Who is it for?
Ages 1 year to 6 years
Conditions the study is for
Arterial Catheterization
What is being tested?
Ulnar artery cannulation and Radial artery cannulation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteCzechia
Study dates
1 May 2022to 31 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 6 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Paediatric patients (1 - 6 years)
  • high risk surgery (significant blood loss or hemodynamic instability)
  • critically ill patients at PICU (respiratory failure, circulatory failure)
  • informed consent

Who cannot join

  • refused to participate
  • arterial catheterization not clinically relevant

Trial locations and contacts

1 site in 1 country.

Jozef UO Klučka, assoc.prof.MD., Ph.D. contact

+420532234696

klucka.jozef@fnbrno.cz

Václav Vafek, MD contact

+420532234696

Vafek.Vaclav@fnbrno.cz

Czechia1 site, 1 recruiting
  • Brno University Hospital

    Brno, South Moravian, 62500

    Petr Štourač, assoc.prof.MD.Ph.D., 532234404 ext. 00420, stourac.petr@fnbrno.cz

    Jozef Klučka, MD, 532234696 ext. 00420, klucka.jozef@fnbrno.cz

    Recruiting

Other trials in Czechia

About this study

Official title: Ulnar Artery Versus Radial Artery Cannulation in Paediatric Patients: a Prospective Randomized Non-inferiority Study

Arterial cannulation is indicated in several clinical settings: high-risk surgery, respiratory failure, circulatory failure. The possible anatomical sites of cannulation are: a.radialis, a.brachialis, a. femoralis. However, the most reported complications in preschool-aged children are associated with femoral and brachial arteries. Therefore, alternative cannulation sites are being searched as ulnar artery, tibial posterior artery.

Read the detailed description

In pediatric patients, artery cannulation may be associated with a higher risk of complications. The preferred puncture site is the radial artery or the femoral artery. However, puncture of the femoral artery in comparison with the radial artery is based on observational data as a significant risk side of post-puncture complications. The radial artery is the dominant artery of the hand, and the collateral supply (via the ulnar artery) is often unable to provide adequate peripheral perfusion. Therefore, other potential sites suitable for artery cannulation in paediatric patients are currently being investigated with the primary goal of increasing safety and reducing the risk of post-puncture complications. According to published studies, the potential alternatives are: posterior tibial artery and ulnar artery. Both arteries have comparable dimensions with radial artery and can be used for USG-guided cannulation. In this prospective randomized trial, patients with clinical indication for arterial cannulation (high-risk surgery, respiratory failure, circulatory failure) undergoing surgery under general anesthesia and pediatric patients admitted into the pediatric intensive care unit (PICU) will be randomized in form of sealed envelopes into a.radialis and a.ulnaris group as the initial site of arterial catheterization. Ultrasound (USG) measurement of both arteries will be performed before the cannulation. The catheterization success rate (number of percutaneous punctures) and overall success rate will be evaluated. The artery will be cannulated under USG control, initially in in-plane view, only in case of insufficient image, or after 2 unsuccessful attempts, the out-of-plane approach could be used. The maximum 5 percutaneous attempts and 10 minutes could be used for the initial (randomized) site of cannulation). In case of cannulation failure, the other artery could be used for cannulation. The rate of complications in 24 hours after cannulation will be evaluated. The arterial catheter will stay in place until the clinical indication remained.

.

Being tested
Ulnar artery cannulation, Radial artery cannulation
Keywords
pediatric anesthesia, pediatric patient, Arterial catheterization, arterial catheter, ultrasound-guided cannulation, Arterial cannulation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ulnar artery cannulationProcedure or surgery

    Also called Ulnar artery catheterization

    Ulnar artery will be cannulated under USG guidance

  • Radial artery cannulationProcedure or surgery

    Also called Radial artery catheterization

    Radial artery will be cannulated under USG guidance

Study groups in NCT05258903
Study groupRoleWhat they receive
Ulnar arteryExperimentalUlnar artery cannulation under USG-guidance
Receives: Procedure: Ulnar artery cannulation
Radial arteryActive comparatorRadial artery cannulation under USG-guidance
Receives: Procedure: Radial artery cannulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. overall puncture success in different arterial sites

    defined by number of required percutaneous punctures and overall site success rate

    Measured: intraoperatively

Secondary outcomes (5)
  1. Arteries anatomical description

    Defined by USG measurement of depth of the artery - (distance from the skin to the upper wall of the artery), cross-sectional area, diameter of the artery.

    Measured: intraoperatively

  2. Technique of the ultrasound-guided cannulation (in-plane/out-of-plane)

    The USG guidance approach will be evaluated

    Measured: intraoperatively

  3. Incidence of complications

    Blood supply disorder, trophic changes, hematoma, arterial wall injury (aneurysm etc.), thrombosis.

    Measured: 24 hours postoperatively

  4. Duration of catheterization

    Time needed for successful catheterization

    Measured: Intraoperatively

  5. Interval between catheterization and catheter removal

    Interval between catheterization and catheter removal will be evaluated

    Measured: 24 hours postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Feb 2022
  2. Study start1 May 2022
  3. Primary completion31 Dec 2023 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Non-inferiority randomized trial
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05258903
Sponsor's protocol ID
KDAR FN Brno Artery
Acronym
ULNART
Status last verified
Jul 2023
First submitted
17 Feb 2022
Last updated
27 Jul 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Ulnar artery cannulation and Radial artery cannulation in people with Arterial Catheterization, run by Brno University Hospital at 1 site in Czechia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Czechia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jozef UO Klučka, assoc.prof.MD., Ph.D. (+420532234696, klucka.jozef@fnbrno.cz), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

overall puncture success in different arterial sites (time frame: intraoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in